Motley Fool // 12.6.18
Canadian cannabis stocks plummeted Thursday after news circulated about the growing concern for the health of the global economy. Top economists warn the US economy could enter a recession by 2020. The claim is largely supported due to the yield of the five-year treasury note falling below that of the three-year note last Monday. Aurora Cannabis (NYSE: ACB), Canopy Growth Corp. (NYSE: CGC), and Cronos Group (NASDAQ: CRON) all fell at least 10% in pre-market trading.
Seeking Alpha // 12.6.18
Rumors regarding Altria Group’s (NSYE: MO) interest in the cannabis industry may be far reaching according to Seeking Alpha’s Grant Beaty. With most of the company’s revenues generated in the US, Altria has explicitly stated that it will not invest in the sector until cannabis is federally legal in the US. Further, Canadian cannabis companies trade at huge valuations that are disproportionate to the value they’d bring to Altria.
Market Watch // 12.6.18
Acreage Holdings Inc. (OTCMKTS: ACRZF) (CSE: ACRG.U) announced Thursday that the company intends to acquire cannabis edibles manufacturer Form Factory Inc. for $160M in stock. Acreage was up 4.4% on the Canadian Securities Exchange at the end of trading on Thursday. The company expects the transaction to close in the first quarter of 2019.
New Cannabis Ventures // 12.6.18
TILT Holdings Inc. (CSE: TILT), a vertically integrated infrastructure and technology platform focusing on the cannabis industry, announced the acquisition of two companies, Blackbird Holdings Corp and Standard Farms, to expand the company’s cultivation and logistics capabilities.
New Cannabis Ventures // 12.6.18
One of the largest vertically integrated cannabis firms in the US, Cresco Labs (CSE: CL), announced a definitive agreement to acquire 100% of the share and membership interests of Hope Heal Health Inc. and an affiliated real estate entity. This segue into the Massachusetts market will add key assets to the company’s national footprint. Hope Heal Health assets include state licensing and registration that will allow for cultivation, manufacturing, processing, and the ability to establish and operate a dispensary.
Proactive Investors // 12.6.18
Thursday Chemistree Technologies Inc. (CSE: CHM) (OTCMKTS: CHMJF) announced that it has signed an agreement with Sugarleaf Farms to acquire the global brand and marketing rights to the Sugarleaf brand outside of Washington.
Bloomberg // 12.5.18
Despite the expense, shorts gained after the Whitney Tilson Conference in New York on Monday. According to Ihor Dusaniwsky, the director of financial analytics firm S3 Partners, as demand to short cannabis stocks grows, the cost to borrow and the frequency of recalled shares is rising. Cannabis stocks handed shorts a $157M mark-to-market gain on Tuesday, driven by losses in Canopy Growth Corp. (NYSE: CGC), Aurora Cannabis (NYSE: ACB), Tilray (NASDAQ: TLRY), and Aphria (NYSE: APHA).
CBC // BNN Bloomberg // 12.5.18
Aphria (NYSE: APHA) shares were falling in premarket trade Wednesday before a short rally. This episode of volatility comes from a report issued by Quintessential Capital Management’s Gabriel Grego warning shareholders about fraudulent and worthless assets the company acquired. SOL Global Investments Corp., the company who sold Aphria their questionable cannabis holdings, issued a statement defending Aphria’s acquisitions. Aphria has vowed to give a line-by-line rebuttal to Grego’s report.
Midas Letter // 12.5.18
Curaleaf Holdings Inc. (CNSX: CURA) (OTCMKTS: CURLF) issued a press release announcing its intention to commence a normal course issuer bid to purchase up to $50M of common stock. Over the past seven trading sessions Curaleaf has lost 36.72% of its value. All shares purchased by the company will be cancelled upon purchase, reducing the number of outstanding shares. Analysts question if other licensed producers will follow the company’s lead and initiate buybacks.
Business Wire // 12.4.18
The first vertically integrated infrastructure and technology cannabis firm, TILT Holdings Inc. is planning nationwide growth across the US. The company announced that it will commence trading on the Canadian Securities Exchange today under the ticker symbol TILT.
Small Cap Power // 12.5.18
With the share-price slump the surrounding the cannabis industry, rumors of consolidation are emerging. Stock-price weakness has turned Organigram Holdings Inc (TSXV: OGI), Aleafia Health Inc. (TSXV: ALEF), and Beleave Inc. (CSE: BE) into three potential takeover targets.
New Cannabis Ventures // 12.4.18
Cannabis management firm MJardin Group Inc. (CSE: MJAR) announced the closing of a $6M minority investment in OG DNA Genetics Inc. as part of a $35M financing completed by DNA Genetics last week.
Barrons // 12.4.18
Aphria (NYSE: APHA) and most marijuana stocks were down Tuesday after a report from Quintessential Capital and Hindenburg Research called the company a shell game that left its shareholders holding worthless assets. The report also claimed Aphria had connections with boom-bust stock Riot Blockchain (NASDAQ: RIOT). The company and analysts came to the company’s defense rebutting the short seller, however the stock was halted for premarket trading for the news.
The Motley Fool // 12.3.18
California-based KushCo Holdings (NASDAQOTH: KSHB) reported its fourth-quarter and year-end financial results, with full-year sales soaring 177% to $52.1M. Though it might take the company a year or two to become profitable on a recurring basis, but the Motley Fool’s Sean Williams considers the stock a “must own.”
Market Watch // 12.4.18
The registered business name for Canada-based CannaRoyalty Corp. (OTC: ORHOF), Origin House announced Tuesday a deal to buy certain assets of California-based cannabis cultivator Cub City LLC for $7.03M. As part of the deal, Origin House will acquire a cultivation facility with a production capacity of 1,400 kilograms of flower per year.
New Cannabis Ventures // 12.4.18
IGC Resources Inc. (TSXV: IGC.H) and Westleaf Cannabis Inc. announced the closing of $20M financing which includes a $2.9M strategic investment from Tilray (NASDAQ: TLRY). Westleaf intends to roll-out its differentiated cannabis concepts across Canada focusing on customer experience and branding. IGC received conditional approval from the TSX Venture Exchange for the proposed RTO transaction.
Growth Op // 12.4.18
Aurora Cannabis (NYSE: ACB) has begun shipping cannabis softgel capsules for the Canadian medical and recreational markets. With a production capacity that could reach 1.4M capsules per week, the company will begin exporting the softgels to international markets in early 2019.
Nasdaq // 12.4.18
Emerald Health Therapeutics Inc. (TSXV: EMH) (OTCQX: EMHTF) announced its joint venture Emerald Health Naturals, has received product licenses from Health Canada to sell proprietary products designed to support the endocannabinoid system. The product line has no cannabinoids and is designed to impact stress, anxiety, restless sleep, pain, and other conditions.
Marlboro cigarette manufacturer Altria Group Inc. (NYSE: MO) has entered into discussions regarding the acquisition of cannabis producer, Cronos Group Inc. (NASDAQ: CRON). No deal has been reached at this time. Altria has also been rumored to be looking to acquire a minority stake in Juul, an e-cigarette company.
Monday, short seller Quintessential Capital Management’s Hindenburg Research alleged Aphria Inc. (NYSE: APHA) insiders used funds from dilutive share issuance to complete unfair acquisitions. Among the numerous allegations, Hindenburg said Aphria was guilty of making overvalued buyouts and posting fraudulent financial reports.
Monday, at the Kase Learning Short Selling Conference in New York, Chris Brown, a partner at long-short firm Aristides Capital, announced his firm has opened up a short position in Tilray (NASDAQ: TLRY). Brown called the cannabis industry a commodity business, and predicted the price of raw cannabis would come down aggressively over time. Tilray fell 2.7% after the hedge fund pitched its position in the company.
Innovation Shares filed a registration statement for a new cannabis ETF earlier this week. The ETF would use a broker-dealer as its custodian rather than a bank. Privately traded broker-dealers are capable of holding stocks on behalf of an investment company without the federal regulatory risks, making them perfect custodians.
Three cannabis stocks turned a legitimate profit in their recently ended quarter. Though Innovative Industrial Properties (NYSE: IIPR) revenues were only $3.93M, the low fixed costs of a REIT have allowed the company to be healthfully profitable. Trulieve Cannabis (NASDAQOTH: TCNNF) recognized $28.3M in sales and Charlotte’s Web Holdings (NASDAQOTH: CWBHF) produced an operating profit of $4M.
48North Cannabis Corp (TSXV: NRTH) announced Monday that it has completed the acquisition of Good & Green. The company also completed a $3M strategic investment financing agreement with Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) fulfilling a $10M private placement. As part of the acquisition, 48North also appointed Jean VanderMarel as co-CEO and a member of the company’s board of directors.
In an all-stock deal, Sunniva (OTCQB: SNNVF) announced that it will acquire San Diego based LTYR Logistics for up to CA$7.9M. LTYR will add a major piece to Sunniva’s vertically integrated seed-to-sale operations in California.
Thursday four leading Farm Bill negotiators from the House and Senate announced that they had reached an agreement in “principal.” If passed, the Farm Bill will legalize industrial hemp, potentially a $22B industry. Companies like Aurora Cannabis (NYSE: ACB) and Canopy Growth Corp. (NYSE: CGC) have been unable to enter the US cannabis sector. If the Farm Bill passes, Canadian cannabis firms will be free to enter the US hemp market.
Closing November strong, CV Sciences Inc. (OTCQX: CVSI) was a top gainer with shares up nearly 8% to $5.31 on the North American Marijuana Index Friday. MariMed Inc was up 2% to $4.09 and GW Pharmaceuticals climbed almost 1% to $122.99. MedMen Enterprises (CSE: MMEN) tumbled 9% and Isodiol International (CSE: ISOL) fell 10% in the index. Tilray (NASDAQ: TLRY) fell nearly 4% and Aurora Cannabis (NYSE: ACB) dipped 0.5%.
After sinking more than 25% in October, the Canadian Cannabis LP Index lost another 14.8% to 799.72. A series of unfortunate events and failed deals has left this index down 20.4% in 2018 and only 9.5% above the August lows. For December the overall index had no changes.
Cresco Labs Inc., formerly Randsburg International Gold Corp., announced that its subordinate voting shares have been approved for listing on the Canadian Securities Exchange under the symbol CL. The company will begin trading today.
With recreational cannabis sales off to a lucrative start in Massachusetts, Boston-based cannabis firm TILT decided the company is going public on Tuesday. The company raised $119M in an equity round of funding and will be listed on the Canadian Securities Exchange under the symbol TILT.
According to Motley Fool’s Sean Williams, Canopy Growth’s (NYSE: CGC) market cap is worth two Aurora companies, proving that production capacity isn’t everything in the cannabis industry. Canopy Growth has many advantages over Aurora including a brand partnership with Constellation Brands (NYSE: STZ) making the company a buyout option. Canopy also has a much less stock dilution than Aurora, who has regularly turned to bought-deal-offerings to raise capital.
Motley Fool’s Joey Frenette believes the cannabis sector is already in the middle of a bear market and advises cannabis investors to take their chips off the gambling table. While most dips have recovered with a bounce, the current downtrend is likely to persist.
Whitney Tilson, former hedge fund manager and the founder of Kase Learning, announced Thursday that pot stocks are a better short today than they were a few months ago. Tilson went further noting that companies must begin trading on fundamentals now that the pump-and-dump crowd has gone.
Alliqua Biomedical Inc. (NASDAQ: ALQA) is soaring nearly 200% after the company announced an agreement Wednesday to spin off its subsidiary AquaMed Technologies and merge it with Israeli cannabinoid pharma therapy company TO Pharmaceuticals LLC. AquaMed manufactures electron beam cross-linked aqueous polymer sheet hydrogel products. The new company TO Pharma will develop novel therapeutics based on proprietary cannabinoid product platform.
Dixie Brands (USA Inc) and Academy Explorations Limited announced that the companies have completed a reverse takeover transaction. Pursuant to the transaction, Academy’s wholly-owned subsidiary Amalco merged with USA Inc. forming Delaware-incorporated operating company named Dixie Brands. New officers and directors were appointed. Dixie Brands is now listed on the Canadian Securities Exchange under the ticker DIXI.U.
For an undisclosed amount, Choom (OTCQB: CHOOF) announced that it has acquired Clarity Cannabis Medical Centres to establish a medical retail cannabis presence. Clarity provides medical cannabis services via its five locations and proprietary telemedicine system.
Thursday Canopy Growth Corp. (NYSE: CGC) announced it has entered into a strategic supply agreement with MediPharm Labs Corp. (OTCMKTS: MLCPF). Under the agreement MediPharm will supply Canopy with up to 900 kilograms of cannabis extract over an 18-month period. In addition, Canopy has committed to purchase 450 kilograms with an option to buy an additional 450 kilograms.
Body and Mind Inc. (CSE: BAMM) (USOTC: BMMJ) and Australis Capital Inc. (CSE: AUSA) announced an investment by Body and Mind into Green Light District holdings Inc. by way of $5.2M senior secured convertible note at a rate of 20% per annum. Body and Mind’s investment was funded partly by a $4M secured loan from Australis.
The North American Marijuana Index recovered Wednesday as cannabis stocks soared after Federal Reserve Chairman Jerome Powell called interest rates just below neutral for the economy. Powell told a group at the Economic Club in New York that its important to distinguish between volatility and events that threaten financial stability. Take a look at who flew and who fell on Wednesday.
Currently holding 49 cannabis stocks including producers and ancillary businesses, Horizons Marijuana Life Sciences Index ETF (NASDAQOTH: HMLSF) has lost more than a third of its value in less than six weeks. Horizons seems to have added many of their listings after those companies’ run-ups had plateaued. Further the industry won’t be returning profits nearly as soon as some expected, which bodes poorly for Horizons Marijuana Life Sciences.
Origin House Corp. (CSE: OH) (OTCQX: ORHOF) announced sequential revenue of $6.6M at a growth of 89% in the company’s financial results for the three- and nine-month periods that ended on September 30, 2018.
CEO Tim McGraw of Canna-Hub, a privately-owned real estate and property development company focused on the cannabis industry, told Proactive Investors the company is making headway on their two cannabis parks under development. According to McGraw Canna-Hub will be expanding to Canada, Nevada, Colorado, and Washington.
Forward enterprise value to revenue is a useful metric to evaluate a stock’s value for early stage companies that have yet to achieve a positive cash flow. In the Canadian cannabis sector the average forward EV/Revenue multiple is 44.6x. These five companies, Harvest One Cannabis Inc. (TSXV: HVT), HEXO Corp (TSX: HEXO), WeedMD Inc (TSXV: WMD), Sunniva Inc. (CSE: SNN), and Supreme Cannabis Company (TSXV: FIRE) (OTC: SPRWF) are all trading below 10.0x forward revenues, well below their peers.
The Supreme Cannabis Company (TSXV: FIRE) (OTC: SPRWF) recently reported its third quarter 2018 updating reflecting sales growth of 229% year-over-year from $1.56M to $5.14M. In an expansion effort, Supreme Cannabis has also reached an agreement to acquire communications firm Bayfield strategy Inc.
NYCanna, a politically affiliated cannabis firm, found itself worth more than $40M after receiving one of New York’s only ten cannabis licenses. Before NYCanna conducted any business with the license they sold the company for $48M to Acreage Holdings LLC (OTCMKTS: ACRZF) (CNSX: ACRG.U) in what some would call a series of sketchy political handshakes.
After raising $30M Altitude Investment Management LLC announced Tuesday that it will close Fund I on November 30, 2018. Beginning Q1 2019 Altitude will be launching Fund II which will focus on the global cannabis industry with investments in plant-touching and ancillary cannabis businesses. Altitude seeks to raise more than $100M for Fund II.
Tuesday Charlotte’s Web Holdings Inc. (CSE: CWEB) (OTCQX: CWBHF) reported their Q3 financial results, highlighting organic revenue growth of 57% to $17.7M compared to 2017 third quarter results. Further, the company’s gross profit, before biological asset adjustment, increased 54% to $13.8M year over year.
Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) announced its third quarter financial report for 2018 on Tuesday. The company’s revenues increased 344% year over year to $17.2M with a 26% quarterly increase. Green Thumb Industries’ net loss was $3.3M, down from a net income of $0.4M in Q2.
48North Cannabis Corp. (TSXV: NRTH) released its financial and operating results for the quarter ending on September 30, 2018. The company reported revenue growth with total 2019 first quarter revenue of $1.3M and adjusted EBITDA of $606K.
Monday Canopy Rivers Inc. (TSXV: RIV) announced its financial results for the three and six months ended on September 30, 2018. Canopy Rivers also provides a corporate update and run down of the company’s eleven partnerships and relationships.
Harvest One (TSXV: HVT) signed an extraction agreement with Valens GroWorks Corp. (CSE: VGW) (OTC: MYMSF). Under the agreement Harvest One’s subsidiary United Greeneries will ship Valens bulk dried cannabis for processing to develop cannabis derivative products.
According to Green Market Report whether you are an acquirer or an investor, performing due diligence on a cannabis firm is deeply nuanced and requires an understanding of how the industry is governed. Take a closer look at some of the diligence issues to keep in mind including transferability of the cannabis business, confirming licenses, banking relationships, cash management, 280E, regulatory compliance, insurance, and criminal issues.
Two years after recreational adult-use cannabis was legalized in Massachusetts sales have finally commenced in the estimated $1.8B market. According to Motley Fool’s Sean Williams MedMen Enterprises (NASDAQOTH: MMNFF), Innovative Industrial Properties (NYSE: IIPR), and KushCo Holdings (NASDAQOTH: KSHB) are flocking to invest in the Massachusetts market.
Monday Acreage Holdings Inc. (CSE: ACRG.U) announced its plans to enter the Michigan cannabis market by entering into an agreement to acquire the real estate assets of Blue Tire Holdings LLC. Together the companies will acquire licenses for the respective properties.
Seeking Alpha’s Jonathan Cooper provides a brief summary on some of the businesses jockeying for position in Florida’s medical cannabis market. With 22 dispensaries, Trulieve Cannabis Corp. (OTCPK: TCNNF) is the state’s top cannabis company followed by Curaleaf Holdings Inc. (OTCPK: LDVTF) with 17 dispensaries. Both MedMen Enterprises (NASDAQ: MMNFF) and Green Thumb Industries Inc. (OTCMKTS: GTBIF) intend to open dispensaries in the state.
With a 36% increase over the previous quarter, Aleafia Health Inc. (TSXV: ALEF) (OTCQX: ALEAF) announced Monday record revenues for Q3 at $1.6M. This marks the first quarter of profitability for clinic and product divisions.
After closing the acquisitions for ICC Labs (NASDAQOTH: ICCLF) and MedReleaf, Motley Fool’s Sean Williams estimates Aurora Cannabis (NYSE: ACB) has the potential to produce up to 1 million kilos of cannabis annually. While Aurora may leave its competitors in the dust in terms of production capacity, investors should beware. Investors should pay attention to Aurora’s need to diversify its product portfolio, find a brand partner, and minimize its ballooning share-based dilution.
Cannex Capital Holdings Inc. (CSE: CNNX) (OTCQX: CNXXF) and 4Front Holdings LLC announced they have signed a binding letter of agreement to which 4Front has agreed to combine with Cannex in an all-stock transaction to create a multi-state, vertically integrated cannabis firm.
The Wayland Group (CSE: WAYL) (FRANKFURT: 75M) (OTCQB: MRRCF) announced it has entered into an agreement to acquire 51% of UK based Theros Pharma Ltd., a small firm that has successfully imported cannabis to the UK for medical cannabis patients.
The Morning Blunt
Volume 3|Issue 26
November 26, 2018
“The best way to predict the future is to create it.”
India Globalization Capital’s Web of Lies
After Market Watch reported last month about potential warning flags, India Globalization Capital (OTC IGCC) plummeted more than 80% and was delisted from the New York Stock Exchange. Including fraud allegations, falsifying data for scientific journals, and lying about partnerships, FDA applications, and distribution agreements, Market Watch has again uncovered evidence raising even more concerns about the IGC’s integrity.
National Access Cannabis Corp. Secures $21M of Special Warrant Financing for 200 Retail Stores
Friday National Access Cannabis Corp. (OTCMKTS: NACNF) announced the closure of its brokered private placement offering of 21,150 special warrants of the company at $1,000 per share for aggregate gross proceeds of $21,150,000 which entitles shareholders to receive 8% senior secured convertible debentures of National Access Cannabis Corp upon exercise or deemed exercise of the special warrants. The funding will help the company open over 200 cannabis retail stores in the next 18 months.
Production Isn’t Everything
Motley Fool’s Sean Williams argues that production capacity is less effective of a metric to measure cannabis stocks than the company’s product diversification, established partnerships, and their position to enter into new markets to establish supply agreements.
What Did Canadian Legalization Do to the Stock Market?
Amplified by the August run-up where index stocks added nearly a third of their values, Cannabis Daily’s Eric Vengroff notes after cannabis legalization Canadian investors bailed, cutting stock prices for many Canadian firms. By way of comparison, the US Marijuana Index has mirrored the volatility of the Canadian market but has proven to be more robust and resilient.
Cannmart & Weed Me Enter Product Acquisition Agreement
Namaste Technologies Inc.’s (OTCMKTS: NXTTF) wholly owned subsidiary, Cannmart Inc., initiated a product acquisition agreement with Weed Me Inc. to purchase a variety of medical cannabis strains in the form of pre-rolled products to offer in its online platform.
Analysis: Terra Tech
Microcap Daily’s Dave Young gives an analysis of Terra Tech Corp (OTCMKTS: TRTC), a Nevada based, vertically integrated, cannabis agriculture firm who recently announced a merger with Golden Leaf Holdings. The new conglomerate will control 41 permits across cultivation, manufacturing, distribution, and retail in Nevada, California, and Oregon.
CSE Aims to Grow US Cannabis Listings in 2019
Due to federal regulations preventing US cannabis companies from listing on US exchanges, and TMX Group’s (OTCMKTS: TMXXF) decision to exclude US operations from its listings, US cannabis firms looking to raise capital are flocking to the Canadian Securities Exchange. This trend could be offset if the States Act, a bill that would remove the federal ban at the state level, is passed.
Aleafia Health Finalizes Joint Venture with Serruya Private Equities
Aleafia Health Inc (TSXV: ALEF) (OTCQX: ALEAF) announced the finalization of the previously announced joint venture and financing transactions with Serruya Private Equities. The two companies will build and scale an immediate national reach with global expansion plans.
Ovation Sciences Newly Trading
Terry Howlett CEO of Ovation Science Inc. (CSE: OVAT) explains the path that led to Ovation choosing to list on the CSE. Ovation’s expertise in skincare is leading the company to explore medicinal CBD products delivered through the skin via Invisicare a patented topical and transdermal delivery system.
Production Capacity: Aurora’s Advantage
According to Motley Fool’s Todd Campbell, production capacity puts Aurora Cannabis (NYSE: ACB) far ahead of Tilray (NASDAQ: TLRY) in terms of inventory and cannabis sales. Assuming Aurora Cannabis delivers on its growth target timeline, the company will ramp-up to 150K kilos annually by 2019.
Trulieve Begins Expansion, Projects $214M Revenue in 2019
Trulieve’s (CSE: TRUL) (OTC: TCNNF) CEO Kim Rivers reports the vertically integrated cannabis firm generated $28.3M of revenue for the company’s third quarter all from the state of Florida. The company recently announced entry into the Massachusetts and California markets and projects Trulieve will rake in $214M in 2019.
According to BDS Analytics and Headset Q3 2018 retail sales data, Plus Products Inc. (CSE: PLUS) is the #1 best-selling cannabis-infused edibles brand in California. PLUS Sour Watermelon Gummies and PLUS Blackberry & Lemon Gummies are the #1 and #2 best-selling branded products across all categories in California including flower, vaporizers, edibles, and topicals.
Nasdaq’s David Goodboy’s lists his reasons for choosing Innovative Industrial Properties (NYSE: IIPR), Tilray (NASDAQ: TLRY), and CV Sciences Inc. (NASDAQ: CVSI) as his top three cannabis related stocks producing revenues.
Canopy Growth Corp. (NYSE: CGC) recovered on Thursday, a day after a slide based on news the company posted a loss in its first quarter since cannabis was legalized in Canada. CEO Bruce Linton goes into the factors that led to the loss.
Acreage Holdings (CSE: ACRG.U) joined the trove of US pot stocks flocking to the Canadian Securities exchange Thursday, after completing a deal to go public that values the company at $2.8B, via reverse takeover. With former House Speaker John Boehner and former Massachusetts Gov. Bill Weld on the board, Acreage Holdings raised $314M from nearly 35 institutional investors.
Kali Inc. (USOTC: KALY) announced the finalization of the acquisition of NCM Biotech, a developer and owner of a patented cannabis extraction process. NCM Biotech’s research and ongoing pharmaceutical developments come with the acquisition.
MediPharm Labs Corp. (TSXV: LABS) announced its subsidiary MediPharm Labs Inc. has entered into a Cannabis Concentrate Program Agreement with Supreme Cannabis Company Inc. (TSXV: FIRE) (OTCQX: SPRWF), where Supreme Cannabis will supply 1,000 kilos of cannabis trim annually to MediPharm for the extraction and production of cannabis oil.